Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.
about
Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.Inflammatory bowel disease unclassified.Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats.Correlation between depression, anxiety, and polymorphonuclear cells' resilience in ulcerative colitis: the mediating role of heat shock protein 70.An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's diseaseEfficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitisSystematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn's disease.Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation.Extracorporeal photopheresis for the treatment of severe, refractory steroid dependent pediatric Crohn's Disease.Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis.Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis.
P2860
Q34008773-85DE8098-05FF-41D7-B9C8-54CDAB5813F7Q34582547-4648D35A-F395-45FF-83F9-26F3C3000F43Q34771646-D6D0F24B-8C16-49B4-BB9A-34BFCA3DC1FAQ35033801-97F129BD-677E-4055-AC4E-D5B4842F9F1EQ35151148-25EC0CDA-9C58-40D8-B83A-F0C538CF4833Q35846531-9CA83EA0-C705-4733-8565-FE1AAAAD57EAQ36859998-1FE755B5-D734-46CE-8638-DD68AEE861F7Q38647797-23F4C64F-0ADC-4A3C-A07C-B718C4D24219Q44086481-DC30AF70-8519-4D1F-B3EE-4A40791CF726Q44303081-AC4852AB-DB6C-4CD6-A28B-623C33473C28Q45067486-392A4E1C-8CF7-485C-805E-F4D3DC25DB7AQ47130594-FF6E54D9-7F1C-4A95-9505-A87D0B79041BQ47694487-EA836928-8D92-43EE-91CC-C93A9CD5DDC8Q48329328-689BC2EA-0E4C-46D0-8F1B-C73B15A3EECA
P2860
Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long-term follow-up with Granu ...... ve inflammatory bowel disease.
@ast
Long-term follow-up with Granu ...... ve inflammatory bowel disease.
@en
type
label
Long-term follow-up with Granu ...... ve inflammatory bowel disease.
@ast
Long-term follow-up with Granu ...... ve inflammatory bowel disease.
@en
prefLabel
Long-term follow-up with Granu ...... ve inflammatory bowel disease.
@ast
Long-term follow-up with Granu ...... ve inflammatory bowel disease.
@en
P2093
P2860
P356
P1433
P1476
Long-term follow-up with Granu ...... ve inflammatory bowel disease.
@en
P2093
Annelie Lindberg
Mats Karlsson
Michael Eberhardson
Per Karlén
P2860
P2888
P356
10.1186/1471-230X-10-73
P577
2010-07-06T00:00:00Z
P5875
P6179
1042887694